AbstractWe present here a new set of aminoglycoside-arginine conjugates (AACs) that are either site-specific or per-arginine conjugates of paromomycin, neamine, and neomycin B as well as their structure–activity relationships. Their binding constants (KD) for TAR and RRE RNAs, measured by fluorescence anisotropy, revealed dependence on the number and location of arginines in the different aminoglycoside conjugates. The binding affinity of the per-arginine aminoglycosides to TAR is higher than to RRE, and hexa-arginine neomycin B is the most potent binder (KD=5 and 23 nM, respectively). The 2D TOCSY NMR spectrum of the TAR monoarginine-neomycin complex reveals binding at the bulge region of TAR
SummaryThe Tat protein and the transactivation responsive (TAR) RNA form an essential complex in the...
The HIV-1 TAR RNA represents a well-known paradigm to study the role of dynamics and conformational ...
The kissing-loop complex that initiates dimeri-zation of genomic RNA is crucial for Human Immunodefi...
AbstractWe present here a new set of aminoglycoside-arginine conjugates (AACs) that are either site-...
AbstractHIV gene expression is crucially dependent on binding of the viral Tat protein to the transa...
AbstractThe potential of RNAs and RNA–protein (RNP) complexes as drug targets is currently being exp...
ABSTRACT Since the origin of first aminoglycosides antibiotics, streptomycin, isolated by...
The ψ region of HIV-1 spans ∼200 nucleotides (nt) near the 5 \u27 end of the RNA genome. This region...
The dimerization initiation site (DIS) of the HIV-1 genomic RNA is a conserved stem-loop that promot...
AbstractThere has been little prior effort to discover new drugs on the basis of a unique RNA struct...
ABSTRACT: Regulation of HIV gene expression is crucially dependent on binding of the trans-activator...
AbstractHIV-1 TAR RNA functions critically in viral replication by binding the transactivating regul...
The binding modes and structural determinants of the noncovalent complexes formed by aminoglycoside ...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...
We recently reported a series of 2,6-dipeptidyl-anthraquinone conjugates (AQs) as Trans-Activation R...
SummaryThe Tat protein and the transactivation responsive (TAR) RNA form an essential complex in the...
The HIV-1 TAR RNA represents a well-known paradigm to study the role of dynamics and conformational ...
The kissing-loop complex that initiates dimeri-zation of genomic RNA is crucial for Human Immunodefi...
AbstractWe present here a new set of aminoglycoside-arginine conjugates (AACs) that are either site-...
AbstractHIV gene expression is crucially dependent on binding of the viral Tat protein to the transa...
AbstractThe potential of RNAs and RNA–protein (RNP) complexes as drug targets is currently being exp...
ABSTRACT Since the origin of first aminoglycosides antibiotics, streptomycin, isolated by...
The ψ region of HIV-1 spans ∼200 nucleotides (nt) near the 5 \u27 end of the RNA genome. This region...
The dimerization initiation site (DIS) of the HIV-1 genomic RNA is a conserved stem-loop that promot...
AbstractThere has been little prior effort to discover new drugs on the basis of a unique RNA struct...
ABSTRACT: Regulation of HIV gene expression is crucially dependent on binding of the trans-activator...
AbstractHIV-1 TAR RNA functions critically in viral replication by binding the transactivating regul...
The binding modes and structural determinants of the noncovalent complexes formed by aminoglycoside ...
AbstractBackground: Aminoglycoside antibiotics can target RNA folds with micromolar affinity and inh...
We recently reported a series of 2,6-dipeptidyl-anthraquinone conjugates (AQs) as Trans-Activation R...
SummaryThe Tat protein and the transactivation responsive (TAR) RNA form an essential complex in the...
The HIV-1 TAR RNA represents a well-known paradigm to study the role of dynamics and conformational ...
The kissing-loop complex that initiates dimeri-zation of genomic RNA is crucial for Human Immunodefi...